JP2025516264A5 - - Google Patents
Info
- Publication number
- JP2025516264A5 JP2025516264A5 JP2024564522A JP2024564522A JP2025516264A5 JP 2025516264 A5 JP2025516264 A5 JP 2025516264A5 JP 2024564522 A JP2024564522 A JP 2024564522A JP 2024564522 A JP2024564522 A JP 2024564522A JP 2025516264 A5 JP2025516264 A5 JP 2025516264A5
- Authority
- JP
- Japan
- Prior art keywords
- hla
- item
- items
- cells
- tcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263337522P | 2022-05-02 | 2022-05-02 | |
| US63/337,522 | 2022-05-02 | ||
| US202263342451P | 2022-05-16 | 2022-05-16 | |
| US63/342,451 | 2022-05-16 | ||
| US202263413553P | 2022-10-05 | 2022-10-05 | |
| US63/413,553 | 2022-10-05 | ||
| US202263423269P | 2022-11-07 | 2022-11-07 | |
| US63/423,269 | 2022-11-07 | ||
| PCT/US2023/020338 WO2023215183A1 (en) | 2022-05-02 | 2023-04-28 | Multiplexed t cell receptor compositions, combination therapies, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025516264A JP2025516264A (ja) | 2025-05-27 |
| JP2025516264A5 true JP2025516264A5 (cg-RX-API-DMAC7.html) | 2026-05-13 |
Family
ID=88646870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564522A Pending JP2025516264A (ja) | 2022-05-02 | 2023-04-28 | 多重化t細胞受容体組成物、その併用療法、及び使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250288675A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4519305A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025516264A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250006149A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119487060A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023265422A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3248253A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024016274A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL316250A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024013482A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202406569A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023215183A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024005746A (es) * | 2021-11-10 | 2024-07-19 | Tscan Therapeutics Inc | Peptidos inmunogenicos magea1, proteinas de union que reconocen peptidos inmunogenicos magea1, y usos de estos. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005113595A2 (en) * | 2004-05-19 | 2005-12-01 | Avidex Ltd | High affinity ny-eso t cell receptor |
| ES2635335T3 (es) * | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| NZ741124A (en) * | 2012-07-27 | 2019-11-29 | Univ Illinois | Engineering t-cell receptors |
| JP6895975B2 (ja) * | 2016-01-06 | 2021-06-30 | ヘルス リサーチ インコーポレイテッドHealth Research, Inc. | 組換えt細胞受容体を含む組成物及びライブラリー並びに組換えt細胞受容体を使用する方法 |
| KR20190062505A (ko) * | 2016-10-03 | 2019-06-05 | 주노 쎄러퓨티크스 인코퍼레이티드 | Hpv-특이적 결합 분자 |
| JP7289028B2 (ja) * | 2018-09-05 | 2023-06-09 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 複数の主要組織適合遺伝子複合体分子に制限したny-eso-1-特異的t細胞受容体の組成物 |
| WO2020167957A1 (en) * | 2019-02-12 | 2020-08-20 | Board Of Regents, The University Of Texas System | High affinity engineered t-cell receptors targeting cmv infected cells |
| DE102019121007A1 (de) * | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Antigenbindende Proteine, die spezifisch an MAGE-A binden |
| EP4010377A4 (en) * | 2019-08-09 | 2023-09-06 | A2 Biotherapeutics, Inc. | CELL SURFACE RECEPTORS THAT RESPOND TO LOSS OF HETEROZYGOSIS |
-
2023
- 2023-04-28 EP EP23799850.5A patent/EP4519305A4/en active Pending
- 2023-04-28 US US18/860,341 patent/US20250288675A1/en active Pending
- 2023-04-28 AU AU2023265422A patent/AU2023265422A1/en active Pending
- 2023-04-28 KR KR1020247038208A patent/KR20250006149A/ko active Pending
- 2023-04-28 WO PCT/US2023/020338 patent/WO2023215183A1/en not_active Ceased
- 2023-04-28 CN CN202380051389.XA patent/CN119487060A/zh active Pending
- 2023-04-28 CA CA3248253A patent/CA3248253A1/en active Pending
- 2023-04-28 TW TW112116024A patent/TW202406569A/zh unknown
- 2023-04-28 JP JP2024564522A patent/JP2025516264A/ja active Pending
- 2023-04-28 IL IL316250A patent/IL316250A/en unknown
-
2024
- 2024-10-31 MX MX2024013482A patent/MX2024013482A/es unknown
- 2024-11-28 CO CONC2024/0016274A patent/CO2024016274A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7770188B2 (ja) | 養子細胞療法のための標的共刺激を提供する受容体 | |
| AU2015230741B9 (en) | Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof | |
| JP5563194B2 (ja) | 改変t細胞レセプターを発現する細胞 | |
| JP2024517618A5 (cg-RX-API-DMAC7.html) | ||
| US20060135418A1 (en) | Receptors | |
| TW201828977A (zh) | 新穎t細胞受體以及使用彼之免疫療法 | |
| KR20190016507A (ko) | TGFβRII의 프레임시프트 돌연변이체를 인식하는 T-세포 수용체 | |
| US12365717B2 (en) | Specific t cell receptors against epitopes of mutant MYD88L265P protein for adoptive T cell therapy | |
| CN114502580B (zh) | Mhc ii类分子及其使用方法 | |
| JP2023549765A5 (cg-RX-API-DMAC7.html) | ||
| EP3898665B1 (en) | Cd22-specific t cell receptors and adoptive t cell therapy for treatment of b cell malignancies | |
| JP2024515646A5 (cg-RX-API-DMAC7.html) | ||
| JP2022546106A (ja) | Ebv-由来抗原に特異的なtcr構築物 | |
| TW202118780A (zh) | Ii類mhc分子及其使用方法 | |
| TW202406569A (zh) | 多重t細胞受體組合物、組合療法及其用途 | |
| Shimizu et al. | Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells | |
| JP2022554349A5 (cg-RX-API-DMAC7.html) | ||
| Savage | Cancer immunotherapy therapeutic manipulation of the CD8-HLA class I interaction: potential and challenges | |
| Subklewe | Current status of immunotherapy in acute myeloid leukemia | |
| EP4577562A1 (en) | Immunotherapeutics based on magea1-derived epitopes | |
| WO2024243807A1 (zh) | 靶向ny-eso-1的高亲和力t细胞受体及其应用 | |
| JP2025541260A (ja) | T細胞受容体 | |
| TW202602496A (zh) | 抗ha-1及抗ha-2結合蛋白用於治療aml、all及mds之用途 | |
| HK40065284A (en) | Receptors providing targeted costimulation for adoptive cell therapy | |
| HK40065284B (en) | Receptors providing targeted costimulation for adoptive cell therapy |